The Mark Foundation has announced the 2026 recipients of its prestigious Momentum Fellowships, recognizing four outstanding early-career investigators and renewing support for five current fellows. Designed to accelerate the careers of promising young scientists, the one-year awards provide critical funding at pivotal moments in their professional development.

Nominated by members of The Mark Foundation’s Scientific Advisory Committee, the Momentum Fellows represent the next generation of leaders driving innovation and discovery in cancer research.

NEW 2026 FELLOWS

Images	Name
	Bastien Dolfi, PhD, University of Lausanne, Switzerland Investigating the Role of Lipid Alterations in Promoting Immunosuppression in Brain Tumor Macrophages
	Brita Ostermeier, PhD, Children’s National Hospital Assessing HIV-Specific T Cells Against Non-Escape Epitope Targets (HST-NEETs) in Combination with a Stress Ligand Chimeric Antigen Receptor (CAR) as a Novel Therapeutic for HIV-Associated Lymphomas
	Constandina Pospori, MB, PhD, Francis Crick Institute Tissue-Infiltrating Clonal Hematopoiesis Dynamics: Investigating a Hidden Enemy Promoting Tumor Initiation
	Constandina Pospori, MB, PhD, Francis Crick Institute Tissue-Infiltrating Clonal Hematopoiesis Dynamics: Investigating a Hidden Enemy Promoting Tumor Initiation

2026 FELLOWSHIP RENEWALS

Images	Name
	Thang DoCong, PhD, University of California Berkeley Discovering Rational Discovery Strategies for Degrading Cancer-Driving Transcription Factors
	Hannah Fay, PhD, Memorial Sloan Kettering Cancer Center KDM3B as a Genotype-Specific Target in IDH1/2-Mutant Clonal Hematopoiesis and
	Pablo Freire, PhD, Dana-Farber Cancer Institute A Novel Class of cis-Regulatory Element Bound by Menin Drives the Expression of Lineage-Restricted Promoters
	Júlia Matas, PhD, Peter MacCallum Cancer Centre, The University of Melbourne Unravelling Non-Genetic Mechanisms of Tumor Evolution Using Real-Time ctDNA Analysis
	Ping Wang, PhD, The University of Pennsylvania Interrogating The Epigenetic Regulatory Modules Driving Exhaustion of Human CAR-T Cells